March 07, 2023 — 04:05 am EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - French stocks were little changed on Tuesday as investors looked for more clues on the outlook for U.S. interest rate hikes.
The dollar slipped while Eurozone short-dated bond yields hovered around multi-year highs, as Federal Reserve Chair Jerome Powell starts his two-day testimony before Congress later in the day. 
The benchmark CAC 40 was marginally higher at 7,379 after rising 0.3 percent the previous day. 
Sanofi rose about 1 percent. Sanofi - Aventis Groupe announced the FDA has accepted, for review, the supplemental Biologics License Application for Dupixent to treat adults and adolescents aged 12 years and older with chronic spontaneous urticaria that is not adequately controlled with the current standard of care. 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.